Your browser doesn't support javascript.
loading
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study.
Romanenko, Victor; Osipova, Irina; Galustyan, Anna; Scherbakov, Michael; Baudson, Nathalie; Farhi, Déborah; Anaya, Luis; Kuriyakose, Sherine O; Meyer, Nadia; Janssens, Winnie.
Affiliation
  • Romanenko V; Children's City Hospital №11 , Ekaterinburg, Russian Federation.
  • Osipova I; OOO "ASKO-MED-PLUS" , Barnaul, Russian Federation.
  • Galustyan A; Medical Technologies Ltd , St. Petersburg, Russian Federation.
  • Scherbakov M; GSK , Moscow, Russian Federation.
  • Baudson N; GSK , Rixensart, Belgium.
  • Farhi D; GSK , Wavre, Belgium.
  • Anaya L; GSK , Wavre, Belgium.
  • Kuriyakose SO; GSK Asia Private Ltd ., Bengaluru, India.
  • Meyer N; GSK , Wavre, Belgium.
  • Janssens W; GSK , Wavre, Belgium.
Hum Vaccin Immunother ; 16(9): 2265-2273, 2020 09 01.
Article in En | MEDLINE | ID: mdl-32048889
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Haemophilus Vaccines / Haemophilus influenzae type b Type of study: Clinical_trials Limits: Child / Humans / Infant Country/Region as subject: Asia / Europa Language: En Journal: Hum Vaccin Immunother Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Haemophilus Vaccines / Haemophilus influenzae type b Type of study: Clinical_trials Limits: Child / Humans / Infant Country/Region as subject: Asia / Europa Language: En Journal: Hum Vaccin Immunother Year: 2020 Type: Article